4/20
08:14 am
sxtp
RedChip's Biotech Investor Conference Replays Now Available [Yahoo! Finance]
Medium
Report
RedChip's Biotech Investor Conference Replays Now Available [Yahoo! Finance]
4/15
08:02 am
sxtp
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
High
Report
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
4/12
01:00 am
sxtp
High
Report
4/9
08:15 am
sxtp
60 Degrees Pharmaceuticals (SXTP) had its price target lowered by Ascendiant Capital Markets from $11.20 to $4.20. They now have a "buy" rating on the stock.
Neutral
Report
60 Degrees Pharmaceuticals (SXTP) had its price target lowered by Ascendiant Capital Markets from $11.20 to $4.20. They now have a "buy" rating on the stock.
4/4
01:05 am
sxtp
Low
Report
3/31
07:12 am
sxtp
60 Degrees Pharmaceuticals Announces 2025 Annual Results [Yahoo! Finance]
Medium
Report
60 Degrees Pharmaceuticals Announces 2025 Annual Results [Yahoo! Finance]
3/31
07:01 am
sxtp
60 Degrees Pharmaceuticals Announces 2025 Annual Results
Medium
Report
60 Degrees Pharmaceuticals Announces 2025 Annual Results
3/21
01:31 am
sxtp
Medium
Report
3/18
08:07 am
sxtp
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract [Yahoo! Finance]
Medium
Report
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract [Yahoo! Finance]
3/18
08:01 am
sxtp
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
High
Report
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
3/11
08:04 am
sxtp
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial [Yahoo! Finance]
High
Report
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial [Yahoo! Finance]
3/11
07:24 am
sxtp
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
High
Report
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
2/27
07:03 pm
sxtp
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
Medium
Report
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
2/24
01:29 pm
sxtp
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA [Yahoo! Finance]
Low
Report
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA [Yahoo! Finance]
2/2
08:13 am
sxtp
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership [Yahoo! Finance]
Medium
Report
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership [Yahoo! Finance]
2/2
08:01 am
sxtp
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
High
Report
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership